Quarterly report pursuant to Section 13 or 15(d)

Consolidated Balance Sheets

v3.23.1
Consolidated Balance Sheets - USD ($)
Apr. 30, 2023
Oct. 31, 2022
CURRENT ASSETS    
Cash and cash equivalents $ 23,455,118 $ 22,927,371
Accounts Receivable, net 3,894,794 2,870,600
Inventory 11,233,685 10,027,111
Unbilled Receivables 1,099,066 602,115
Prepaid Expenses 738,167 240,464
Other Current Assets 422,371 343,061
Total Current Assets 40,843,201 37,010,722
FIXED ASSETS    
Property and Equipment, net 6,070,666 5,832,532
OTHER ASSETS    
Goodwill and Other Intangibles, net 3,851,229 3,824,394
Deferred Tax Asset 138,366 259,810
Total Other Assets 3,989,595 4,084,204
Total Assets 50,903,462 46,927,458
CURRENT LIABILITIES    
Accounts Payable 776,185 793,247
Accrued Expenses and Other Current Liabilities 704,521 1,731,706
Deferred Revenue 1,023,757 943,569
Total Current Liabilities 2,504,463 3,468,522
LONG TERM LIABILITIES    
Deferred Revenue, less current portion 88,258 76,127
Total Liabilities 2,592,721 3,544,649
STOCKHOLDERS’ EQUITY    
Common Stock, $.001 par value; 150,000,000 shares authorized, 11,042,897 issued and outstanding as of April 30, 2023 and 10,916,853 shares issued and outstanding as of October 31, 2022 11,043 10,918
Treasury Stock (31,175) (28,337)
Additional Paid-in Capital 62,692,276 62,313,988
Accumulated Other Comprehensive Loss (2,591,101) (4,737,124)
Accumulated Deficit (11,770,302) (14,176,636)
Total Stockholders’ Equity 48,310,741 43,382,809
Total Liabilities and Stockholders’ Equity $ 50,903,462 $ 46,927,458